Publication | Closed Access

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis

Cost-effectiveness AnalysisMedicineNext-generation SequencingPathologyCancer GenomicsBronchial NeoplasmMolecular DiagnosticsIncremental YieldOncologyRadiation OncologyLung Cancer